Annual Drug Patent Expirations for SKYCLARYS
Skyclarys is a drug marketed by Reata Pharms and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
This drug has seventy-three patent family members in thirty-five countries.
The generic ingredient in SKYCLARYS is omaveloxolone. One supplier is listed for this compound. Additional details are available on the omaveloxolone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com